EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC-ND 4.0

Diagnosis and Metabolic Management of Adult Refsum Disease: Guidance From the Medical and Scientific Committee of Global DARE (Defeat Adult Refsum Everywhere)

Radha Ramachandran iD, Raphael Buttigieg, Florian Eichler, Bart P Leroy, Omar Mahroo, Rachel M Huckfeldt, Sarah Firman, Eleanor Baldwin, Kristie DeMarco, Susan Kuranoff, Amena Fine, Reinhard Klingel und 4 weitere

Journal of Inherited Metabolic Disease · 2026-05 · 49 (3)

DOI: 10.1002/jimd.70201 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 20.05.2026. Verfasst von Radha Ramachandran und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Adult Inherited Metabolic Diseases, Guy's & St Thomas' Hospitals NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Refsum Disease. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adult Refsum disease (ARD; OMIM 266510) is a degenerative autosomal recessive condition typically diagnosed in adulthood. It affects visual, auditory and nervous system function. It is characterised by plasma, neuro‐ophthalmological and adipose tissue accumulation of the dietary‐derived phytanic acid (PA). This guidance reviews the clinical aspects of ARD and discusses interventions to address various co‐morbidities of the disease. This GRADE‐aligned guidance is based on a review of the literature and a consensus statement reflecting the conclusions of professionals with experience in the diagnosis and management of ARD. This statement reviews clinical aspects of ARD and discusses current and potential interventions to address various symptoms of the disease. It provides an overview of the clinical phenotype, reviews the clinical, biochemical, and genetic findings in ARD, and the neurological and ophthalmological investigations needed at diagnosis and during follow‐up. It highlights the importance of dietary management and its role in situations such as acute hospital admissions for inter‐current illness. Furthermore, it provides guidance on the acute management of decompensation in ARD and outlines when therapeutic plasma exchange/lipoprotein plasmapheresis should be considered. Greater clinician and patient awareness will lead to early diagnosis and improved outcomes. Implementation of a low PA diet before further end organ involvement offers the best prognosis. Life‐long dietary therapy, along with therapeutic plasma exchange/lipoprotein apheresis during acute decompensations, remains the mainstay of management. Patients should have access to a multidisciplinary team to ensure specialist dietary input and supportive management of comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Refsum DiseaseHumansPhytanic AcidAdultPhenotype

Stichwörter der Autor:innen

ARDadult Refsum diseasephytanatephytanic acid

Substanzen

Phytanic Acid

Autor:innen und Institutionen

  • Department of Adult Inherited Metabolic Diseases, Guy's & St Thomas' Hospitals NHS Foundation Trust, London, UK.
  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Ophthalmology & Center for Medical Genetics, Ghent University Hospital & Department of Head & Skin, Ghent University, Ghent, Belgium.
  • Moorfields Eye Hospital, London, UK.
  • Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
  • Global DARE Foundation, Windham, Maine, USA.

ORCID-Profile: Radha Ramachandran

Förderung

  • NINDS NIH HHS

Zitieren

APA

Ramachandran, R., Buttigieg, R., Eichler, F., Leroy, B. P., Mahroo, O., Huckfeldt, R. M., Firman, S., Baldwin, E., DeMarco, K., Kuranoff, S., Fine, A., Klingel, R., Ferdinandusse, S., Hacia, J. G., Wanders, R. J., & Wierzbicki, A. S. (2026). Diagnosis and Metabolic Management of Adult Refsum Disease: Guidance From the Medical and Scientific Committee of Global DARE (Defeat Adult Refsum Everywhere). Journal of Inherited Metabolic Disease, 49(3). https://doi.org/10.1002/jimd.70201

Vancouver

Ramachandran R, Buttigieg R, Eichler F, Leroy BP, Mahroo O, Huckfeldt RM, et al. Diagnosis and Metabolic Management of Adult Refsum Disease: Guidance From the Medical and Scientific Committee of Global DARE (Defeat Adult Refsum Everywhere). Journal of Inherited Metabolic Disease. 2026;49(3). doi:10.1002/jimd.70201

BibTeX
@article{Ramachandran2026,
  author = {Ramachandran, Radha and Buttigieg, Raphael and Eichler, Florian and Leroy, Bart P and Mahroo, Omar and Huckfeldt, Rachel M and Firman, Sarah and Baldwin, Eleanor and DeMarco, Kristie and Kuranoff, Susan and Fine, Amena and Klingel, Reinhard and Ferdinandusse, Sacha and Hacia, Joseph G and Wanders, Ronald J and Wierzbicki, Anthony S},
  title = {Diagnosis and Metabolic Management of Adult Refsum Disease: Guidance From the Medical and Scientific Committee of Global DARE (Defeat Adult Refsum Everywhere)},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {3},
  doi = {10.1002/jimd.70201}
}
Kostenlos starten →